openPR Logo
Press release

Rotavirus Infections Therapeutics Market Pegged for Robust Expansion by 2025

03-15-2018 09:24 AM CET | Health & Medicine

Press release from: Transparency Market Research

Rotavirus Infections Therapeutics Market Pegged for Robust

Rotavirus infections cause vomiting and diarrhea that leads to severe dehydration. Despite widespread cell death and tissue damage, the inflammatory reaction is quite limited. Rotavirus is the major cause of acute gastroenteritis in young children globally, and accounts for 600,000 child deaths each year, with the majority of deaths occurring in Middle East & Africa and Asia Pacific. The primary clinical symptoms of rotavirus infections are severe vomiting and diarrhea, including fever. Introduction of rotavirus vaccines has reduced the mortality in the last decade; however, rotavirus infections have major clinical significance and disease mechanisms needs to be understood.

The rotavirus infection affects people across the globe, and leads to regardless environmental conditions or socioeconomic status. The consequences and outcomes of rotavirus infections differ significantly in developing and developed countries. The mortality rate is high in children with poor access to medical care. The primary cause of death in children is electrolyte imbalance and dehydration. Mortality rate has been decreased in developed countries; however, rotavirus infection causes significant morbidity and considerable number of hospitalization among children.

Rotavirus vaccine is the best way to avoid rotavirus infection in children. The Centers for Disease Control and Prevention has recommended routine vaccination of newborns with available vaccines in the market.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39545

The global Rotavirus Infections Therapeutics Market can be segmented based on route of administration, distribution channel, and region. In terms of route of administration, the global market can be categorized into oral and parenteral. Based on distribution channel, the global rotavirus infections therapeutics market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. Currently, there are no specific therapies or therapeutics available to treat rotavirus infection. Several pharmaceutical companies have therapeutics in pipeline for treatment of rotavirus infections.

Geographically, the global rotavirus infections therapeutics market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America rotavirus infections therapeutics market is segmented in to U.S., and Canada. Europe rotavirus infections therapeutics market is segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. Asia pacific rotavirus infections therapeutics market is further segmented into Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific. Latin America rotavirus infections therapeutics market is segmented into Mexico, Brazil, and Rest of Latin America.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39545

Where Middle East and Africa rotavirus infections therapeutics market is segmented into Saudi Arabia, South Africa, Israel, and Rest of Middle East and Africa. The prevalence of rotavirus infections is higher in Asia Pacific and Middle East & Africa as compared to North America and Europe. According to statistics published by World Health Organization (WHO) in 2016, the highest cases of rotavirus infection were detected in Asia Pacific and lowest in Latin America. The dominance of Asia Pacific is attributed to the increasing prevalence of rotavirus disorders in Asian children, combined with the efficacy of rotavirus vaccines to prevent hospitalizations and childhood deaths, emphasizes the incredible potential for the introduction of rotavirus vaccines in developing countries of Asia Pacific region to protect children from rotavirus infection.

Key players developing therapeutics for rotavirus infections are GlaxoSmithKline, Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd., Biological E Ltd., Curevac AG, MEDICAGO, UNM Pharma, Inc., Wuhan Institute of Biological Products Co., Ltd., Ology Bioservices, and Serum Institute of India Pvt. Ltd.

View Report -

https://www.transparencymarketresearch.com/rotavirus-infections-therapeutics-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rotavirus Infections Therapeutics Market Pegged for Robust Expansion by 2025 here

News-ID: 979323 • Views: 164

More Releases from Transparency Market Research

Covid-19 Impact on Organic Turmeric Market: Present Scenario and Future Growth P …
The report details an exhaustive account of the global organic turmeric market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2026. From an overall perspective, the report is expected to exist as a valuable insight
Organic Emulsifiers Market: Growth-Projections, Innovative, Opportunities, Advan …
Organic Emulsifiers Market: Overview The international market for organic emulsifiers has been gaining impetus as small to large companies dedicate resources in the research and development work for the purpose of development of more effective and affordable creams for the purpose that it is supposed to serve. Organic emulsifiers are also known as natural emulsifiers. Obtain Report Details @ https://www.transparencymarketresearch.com/organic-emulsifiers-market.html The report has been segmented on the basis of various key parameters
Organic Sausage Market : Development Status Highlighted During Forecast Period 2 …
Global Organic Sausage Market: Overview The global market for sausages has witnessed steady expansion over the years and has witnessed vast transformations in terms of contents and ingredients that combine to make conventional sausage. In times before refrigeration systems were not as ubiquitous as present times, sausages were cured with spices and sale for later consumption. Obtain Report Details @ https://www.transparencymarketresearch.com/organic-sausage-market.html With a variety of fillers and binders such as cereals, rice,
Polyisobutylene Market at a CAGR of 5.60%
Transparency Market Research (TMR) witnesses the global polyisobutylene market has a highly fragmented competitive scenario. Some of the companies operating in the global polyisobutylene market are Lanxess, Nizhekamskneftekhim, and ExxonMobil Corp. accounted for 65% in 2016. The key players in this market have taken up profoundly imaginative marketing systems, for example, incorporated tasks with licensed innovations for the further advancement of their organizations. These organizations are additionally expected to forcefully

All 5 Releases


More Releases for Asia

RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
MES: Expansion in Asia
Berlin, November 24, 2014: Model Engineering Solutions (MES), the Berlin-based specialist for model-based software development, has significantly expanded its business in Asia. In recent years, MES has built up a network of local partners in Japan, Korea, China, and India in order to benefit from the growing market and increasing interest in model-based development and ISO 26262 in Asia. Asia: Driving force in the automotive industry The automotive industry continues
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
UDT Asia 2011
Clarion Events hosts the Undersea Defence Technology (UDT) Asia 2011 conference and exhibition to bring senior naval and industry personnel together to cover underwater developments in the region Singapore, May 30 – Clarion Events is hosting UDT Asia on 30 November – 1 December 2011. The event brings together the undersea defence community in Asia, featuring top regional naval speakers, who will be addressing the latest underwater requirements for Asian navies. According
eltherm goes Asia
Finally all preparations are finished and the new subsidiary of eltherm GmbH, eltherm Asia Pacific Pte Ltd has commenced operations in Singapore on 1st April 2010. To celebrate the starting shot, an opening celebration was held in the afternoon of 28th July in the office premises followed by a get together dinner and drinks in the evening at a pub. A total of 62 guests attended the event with the